Hong Kong suspended use of thevaccine Wednesday after its distributor informed the city that one batch had defective bottle lids.
The city’s government said the suspension was immediate while the matter is investigated by distributorand , the company which created the vaccine with pharmaceutical firm Pfizer.
BioNTech andhave not found any reason to believe the product is unsafe, according to the statement. However, vaccinations will be halted as a preventive and safety measure.
The defective lids were found on vaccines from batch number 210102. A separate batch of vaccines, 210104, will also be not be administered.
Macao also said Wednesday that residents would not receive thevaccinations from the affected batch.
BioNTech andcould not be immediately reached for comment.
All community centers inadministering the vaccine have temporarily suspended vaccinations and residents who already made appointments for Wednesday need not proceed to the centers, the government said.
The suspension of thejab means the only vaccine currently offered to residents is China’s vaccine. The two vaccines are the only ones that were offered to residents in Hong Kong.
German expatriate Janniswas among a group of people who received the shot ahead of the suspension.
“I got vaccinated this morning at 8.30 a.m. before the news went public about the vaccine suspension, and heard the news when I was on my way home,” said 32-year-old, who works in the sporting goods industry.
“I’m not very concerned about the safety, but I am worried that this may mean more people will turn down the option of getting vaccinated inwhich would impact herd immunity and the lifting of social-distancing measures,” he said.
Some residents who had appointments Wednesday morning stood in line outside a community center administering thevaccinations in the city’s Pun neighborhood at about 10.30 a.m. They eventually left the center when it became apparent that no vaccines would be administered.
As of 8 p.m. Tuesday, 403,000 people have received vaccines in the city, of which 150,200 had received the first dose of thevaccine, compared with 252,800 who had taken the jab.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)